Market Tracker

08/16 11:18am ET

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

1.32
Delayed Data
As of 11:01am ET
 +0.01 / +0.76%
Today’s Change
1.20
Today|||52-Week Range
28.40
-74.58%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close1.31
Today’s open1.30
Day’s range1.27 - 1.34
Volume39,289
Average volume (3 months)274,780
Market cap$14.3M
Dividend yield--
Data as of 11:01am ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)-62.63%
Earnings growth (this year)--
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)-95.45%
P/E ratioNM
Price/Sales184.93
Price/Book1.95

Competitors

 Today’s
change
Today’s
% change
CBIOCatalyst Biosciences...+0.00+0.05%
IMRNImmuron Ltd+0.41+7.77%
ABIOARCA Biopharma Inc0.000.00%
EVARLombard Medical Inc+0.01+2.48%
Data as of 11:13am ET, 08/16/2017

Financials

Last reporting dateAugust 9, 2017
EPS forecast (this quarter)-$1.09
Annual revenue (last year)$145.0K
Annual profit (last year)-$55.5M
Net profit margin-38,291.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Craig Thompson
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts